GenHarp Clinical Solutions

Evergreen Park, Illinois 60805-2758

0 studies enrolling now · 5 studies all time

What they study most

Advanced Solid Tumours, Covid19, Hypertension, Idiopathic Pulmonary Fibrosis, Non-Small Cell Lung Cancer, Post-acute COVID-19 Respiratory Disease, Small Cell Lung Cancer, Systemic Sclerosis With Lung Involvement

Studies at this site

• LYT-100 in Post-acute COVID-19 Respiratory Disease — Stopped early
• A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease — Stopped early
• A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen — Completed
• Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies — Completed
• IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer — Completed